Infinity Pharmaceuticals Competitors and Similar CompaniesClear all
GlycoMimetics's competitors and similar companies include Iovance Biotherapeutics.
 GlycoMimetics GlycoMimetics is a biopharmaceutical company designing and developing small molecule therapeutics to treat various cancers. |  Iovance Biotherapeutics Iovance Biotherapeutics (formerly Lion Biotechnologies) is focused on the development and commercialization of novel cancer immunotherapies based on tumor infiltrating lymphocytes. | |
Founding Date | Founding Date 2003 | Founding Date 2013 |
Type | Type Public | Type Public |
Tags | ||
Locations | Locations Rockville, US HQ | Locations San Carlos, US HQ New York, US Philadelphia, US Philadelphia, US Tampa, US |
Employees | Employees 5025% increase | Employees 14868% increase |
Valuation ($) | Valuation ($) 31.6 m | Valuation ($) 3.3 b |
Financial | ||
Revenue (est.) | Revenue (est.) $10.8m (FY, 2025) | Revenue (est.) $263.5m (FY, 2025) |
Funding | ||
Total funding raised | Total funding raised $ 101.8m | Total funding raised $ 100m |
For sources of this data, please see the company profile
View Company Profiles
Iovance Biotherapeutics
HQ
San Carlos, US
Employees
148
Iovance Biotherapeutics (formerly Lion Biotechnologies) is focused on the development and commercialization of novel cancer immunotherapies based on tumor infiltrating lymphocytes.
View company